Market Currents

• Monday, November 9, 2009

• 07:45 AM GTx (GTXI): Q3 EPS of -$0.35 in-line. Revenue of $3.6M (+20%) vs. $4M. (PR) Comment!
• 00:05 AM Notable premarket earnings: DISH, ENER, GTXI, HPT, KWK, NHP, ROK, SRE, TSO, WCRX, WIN, WNR Comment!

• Monday, November 2, 2009

• 08:53 AM FDA rejects GTx Inc.'s (GTXI -33%) experimental drug to reduce bone fractures in men with prostate cancer, citing clinical deficiencies. Comment!